Ghayal Nikhil B, Roemer Shanu F, Tipton Philip W, Jiang Peizhou, Selner Elizabeth M, Peck Dawn S, Murakami Aya, Oglesbee Devin, Graff-Radford Neill R, Dickson Dennis W
Department of Neuroscience, Mayo Clinic, Jacksonville, FL.
Department of Neurology, Mayo Clinic, Jacksonville, FL.
Neurol Genet. 2024 Dec 23;11(1):e200227. doi: 10.1212/NXG.0000000000200227. eCollection 2025 Feb.
In this study, we describe a 54-year-old Indian woman who presented with clinical features of Kufs syndrome A (KSA) and Kufs syndrome B (KSB), as well as neuropathologic and genetic findings consistent with neuronal ceroid lipofuscinosis type 13 (CLN13). Subsequently, we review the clinicopathologic features of 20 patients with CLN13 reported in the literature.
Data and imaging were obtained from the patient's medical records. The patient was examined neuropathologically, and next-generation sequencing was performed.
Clinical radiologic scans revealed bilateral cortical atrophy, ventriculomegaly, a thin corpus callosum, and cerebellar vermian atrophy. Pathologic examination was remarkable for NCL. Postmortem genetic testing revealed a homozygous () indel variant. A review of 20 reported CLN13 patients revealed novel clinical subtypes, including KSB type I (KSB-I), KSB type II (KSB-II), and Kufs syndrome C (KSC).
CLN13 was clinically heterogeneous. Most patients with CLN13 (14/20) did not present with classic KSB (KSB-I). Instead, 6 patients presented with KSB-II, 4 patients presented with KSC (including the present patient), and 3 patients presented with dementia. Our results expand the CLN13 clinical spectrum and emphasize the importance of screening variants in clinical dementia and movement disorder cohorts.
在本研究中,我们描述了一名54岁的印度女性,她表现出库夫斯综合征A(KSA)和库夫斯综合征B(KSB)的临床特征,以及与13型神经元蜡样脂褐质沉积症(CLN13)一致的神经病理学和遗传学发现。随后,我们回顾了文献中报道的20例CLN13患者的临床病理特征。
从患者的病历中获取数据和影像学资料。对患者进行神经病理学检查,并进行下一代测序。
临床放射学扫描显示双侧皮质萎缩、脑室扩大、胼胝体变薄和小脑蚓部萎缩。病理检查显示神经细胞蜡样脂褐质沉积症显著。死后基因检测发现一个纯合的()插入缺失变异。对20例报道的CLN13患者的回顾揭示了新的临床亚型,包括KSB I型(KSB-I)、KSB II型(KSB-II)和库夫斯综合征C(KSC)。
CLN13在临床上具有异质性。大多数CLN13患者(14/20)未表现出典型的KSB(KSB-I)。相反,6例患者表现为KSB-II,4例患者表现为KSC(包括本患者),3例患者表现为痴呆。我们的结果扩展了CLN13的临床谱,并强调了在临床痴呆和运动障碍队列中筛查变异的重要性。